E. M. Onal Et Al. , "Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3, pp.197-209, 2017
Onal, E. M. Et Al. 2017. Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3 , 197-209.
Onal, E. M., Sag, A. A., Sal, O., Yerlikaya, A., AFŞAR, B., & Kanbay, M., (2017). Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3, 197-209.
Onal, Emine Et Al. "Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3, 197-209, 2017
Onal, Emine M. Et Al. "Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3, pp.197-209, 2017
Onal, E. M. Et Al. (2017) . "Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.39, no.3, pp.197-209.
@article{article, author={Emine Meltem Onal Et Al. }, title={Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension}, journal={CLINICAL AND EXPERIMENTAL HYPERTENSION}, year=2017, pages={197-209} }